Shop
QualityLab ResultsPartner
Log In

BPC-157 + TB-500 Kit Safety Data Sheet

Prepared in the 16-section format of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), as required by the OSHA Hazard Communication Standard (29 CFR 1910.1200).

Last Updated: Revision: 1.0Supplier: Peptide.Express

Substance Identity

CAS Numbers
137525-51-0, 77591-33-4
Synonyms
Separate-Vial Wolverine Stack Components
GHS Signal Word
Warning
Appearance
White to off-white lyophilized powder
GHS hazard statements for BPC-157 + TB-500 Kit
CodeHazard Statement
H315Causes skin irritation.
H319Causes serious eye irritation.
H335May cause respiratory irritation.
H361Suspected of damaging fertility or the unborn child.

For Research Use Only — Not for Human Consumption

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

1.1 Product Identifier

Product Name
BPC-157 + TB-500 Kit
Synonyms
Separate-Vial Wolverine Stack Components
CAS Numbers
  • BPC-157: 137525-51-0
  • TB-500: 77591-33-4

1.2 Relevant Identified Uses of the Substance or Mixture and Uses Advised Against

Identified Uses
Laboratory research and development.
Uses Advised Against
Not for human consumption, diagnostic, therapeutic, or clinical use.

1.3 Details of the Supplier of the Safety Data Sheet

Supplier
Peptide.Express
Website
https://peptide.express
Phone
Contact via website

1.4 Emergency Telephone Number

Emergency Contact
Contact local poison control center or emergency services.

Section 2: Hazards Identification

2.1 Classification of the Substance or Mixture

Skin Irritation
Category 2
Eye Irritation
Category 2A
Specific Target Organ Toxicity - Single Exposure (Respiratory Tract Irritation)
Category 3
Reproductive Toxicity
Category 2

2.2 GHS Label Elements, Including Precautionary Statements

Hazard Pictograms
  • GHS07 (Exclamation Mark)
  • GHS08 (Health Hazard)
Signal Word
Warning

Hazard Statements

H315
Causes skin irritation.
H319
Causes serious eye irritation.
H335
May cause respiratory irritation.
H361
Suspected of damaging fertility or the unborn child.

Precautionary Statements

P261
Avoid breathing dust/fume/gas/mist/vapors/spray.
P264
Wash skin thoroughly after handling.
P271
Use only outdoors or in a well-ventilated area.
P280
Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352
IF ON SKIN: Wash with plenty of water.
P305+P351+P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312
Call a POISON CENTER/doctor if you feel unwell.
P321
Specific treatment (see supplemental first aid instructions on this label).
P332+P313
If skin irritation occurs: Get medical advice/attention.
P337+P313
If eye irritation persists: Get medical advice/attention.
P362
Take off contaminated clothing and wash it before reuse.
P403+P233
Store in a well-ventilated place. Keep container tightly closed.
P405
Store locked up.
P501
Dispose of contents/container to an approved waste disposal plant.

2.3 Other Hazards

  • None known.

Section 3: Composition/Information on Ingredients

3.1 Substances / Mixtures

This product is a kit containing two separate lyophilized vials.

Component 1: BPC-157

Chemical Name
BPC-157
Sequence
GEPPPGKPADDAGLV
CAS Number
137525-51-0
Molecular Formula
C62H98N16O22
Molecular Weight
1419.5 Da
Concentration
100% (per vial)

Component 2: TB-500

Chemical Name
Synthetic Thymosin beta-4
CAS Number
77591-33-4
Molecular Formula
C212H350N56O78S
Molecular Weight
4963.4 Da
Concentration
100% (per vial)

Section 4: First Aid Measures

4.1 Description of First Aid Measures

General Advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If Inhaled
Move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In Case of Skin Contact
Wash off with soap and plenty of water. Consult a physician.
In Case of Eye Contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If Swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

4.2 Most Important Symptoms and Effects, Both Acute and Delayed

  • The most important known symptoms and effects are described in the labeling (see section 2.2) and/or in section 11.

4.3 Indication of Any Immediate Medical Attention and Special Treatment Needed

  • No data available. Treat symptomatically.

Section 5: Firefighting Measures

5.1 Extinguishing Media

Suitable Extinguishing Media
Use water spray, alcohol-resistant foam, dry chemical, or carbon dioxide.

5.2 Special Hazards Arising from the Substance or Mixture

  • Carbon oxides, Nitrogen oxides (NOx), Sulfur oxides (for TB-500).

5.3 Advice for Firefighters

  • Wear self-contained breathing apparatus for firefighting if necessary.

5.4 Further Information

  • No data available.

Section 6: Accidental Release Measures

6.1 Personal Precautions, Protective Equipment and Emergency Procedures

  • Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist, or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.

6.2 Environmental Precautions

  • Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

6.3 Methods and Materials for Containment and Cleaning Up

  • Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.

6.4 Reference to Other Sections

  • For disposal see section 13.

Section 7: Handling and Storage

7.1 Precautions for Safe Handling

  • Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2.

7.2 Conditions for Safe Storage, Including Any Incompatibilities

  • Keep container tightly closed in a dry and well-ventilated place.
Storage Conditions
  • Long-term storage: -20°C
  • Short-term storage: 2-8°C
Special Requirements
Protect from light and moisture. Store locked up.

7.3 Specific End Use(s)

  • Laboratory research and development.

Section 8: Exposure Controls/Personal Protection

8.1 Control Parameters

Components with Workplace Control Parameters
Contains no substances with occupational exposure limit values.

8.2 Exposure Controls

Appropriate Engineering Controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Personal Protective Equipment
Eye/Face Protection
Safety glasses with side-shields conforming to EN166. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin Protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Impervious clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory Protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator. For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of Environmental Exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

Section 9: Physical and Chemical Properties

9.1 Information on Basic Physical and Chemical Properties

Appearance
White to off-white lyophilized powder
Odor
Odorless
Odor Threshold
No data available
pH
3.0-5.0 in solution
Melting Point/Freezing Point
Decomposes before melting for peptides
Initial Boiling Point and Boiling Range
No data available
Flash Point
No data available
Evaporation Rate
No data available
Flammability (Solid, Gas)
No data available
Upper/Lower Flammability or Explosive Limits
No data available
Vapor Pressure
No data available
Vapor Density
No data available
Relative Density
No data available
Water Solubility
Soluble in water, DMSO, dilute acetic acid
Partition Coefficient (n-octanol/water)
No data available
Auto-ignition Temperature
No data available
Decomposition Temperature
No data available
Viscosity
No data available
Explosive Properties
No data available
Oxidizing Properties
No data available

9.2 Other Safety Information

  • No data available.

Section 10: Stability and Reactivity

10.1 Reactivity

  • No data available.

10.2 Chemical Stability

  • Stable under recommended storage conditions.

10.3 Possibility of Hazardous Reactions

  • No data available.

10.4 Conditions to Avoid

  • Light, moisture, and extreme temperatures.

10.5 Incompatible Materials

  • Strong oxidizing agents, strong acids, strong bases.

10.6 Hazardous Decomposition Products

  • Hazardous decomposition products formed under fire conditions: Carbon oxides, Nitrogen oxides (NOx), Sulfur oxides.
  • Other decomposition products: No data available.
  • In the event of fire: see section 5.

Section 11: Toxicological Information

11.1 Information on Toxicological Effects

Acute Toxicity
No data available.
Skin Corrosion/Irritation
Causes skin irritation.
Serious Eye Damage/Eye Irritation
Causes serious eye irritation.
Respiratory or Skin Sensitization
No data available.
Germ Cell Mutagenicity
No data available.
Carcinogenicity
  • IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
Reproductive Toxicity
Suspected of damaging fertility or the unborn child.
Specific Target Organ Toxicity - Single Exposure
May cause respiratory irritation.
Specific Target Organ Toxicity - Repeated Exposure
No data available.
Aspiration Hazard
No data available.
Additional Information
RTECS: Not available. To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.

Section 12: Ecological Information

12.1 Toxicity

  • No data available.

12.2 Persistence and Degradability

  • No data available.

12.3 Bioaccumulative Potential

  • No data available.

12.4 Mobility in Soil

  • No data available.

12.5 Results of PBT and vPvB Assessment

  • PBT/vPvB assessment not available as chemical safety assessment not required/not conducted.

12.6 Other Adverse Effects

  • No data available.

Section 13: Disposal Considerations

13.1 Waste Treatment Methods

Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated Packaging
Dispose of as unused product.

Section 14: Transport Information

14.1 UN Number

  • ADR/RID: -
  • IMDG: -
  • IATA: -

14.2 UN Proper Shipping Name

  • ADR/RID: Not dangerous goods
  • IMDG: Not dangerous goods
  • IATA: Not dangerous goods

14.3 Transport Hazard Class(es)

  • ADR/RID: -
  • IMDG: -
  • IATA: -

14.4 Packaging Group

  • ADR/RID: -
  • IMDG: -
  • IATA: -

14.5 Environmental Hazards

  • ADR/RID: no
  • IMDG Marine pollutant: no
  • IATA: no

14.6 Special Precautions for User

  • Not regulated for transport (non-hazardous goods).

Section 15: Regulatory Information

15.1 Safety, Health and Environmental Regulations/Legislation Specific for the Substance or Mixture

  • This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006 and GHS standards.

15.2 Chemical Safety Assessment

  • For this product a chemical safety assessment was not carried out.

Section 16: Other Information

Full Text of H-Statements Referred to Under Sections 2 and 3

H315
Causes skin irritation.
H319
Causes serious eye irritation.
H335
May cause respiratory irritation.
H361
Suspected of damaging fertility or the unborn child.

Preparation Information

Prepared By
Peptide.Express Regulatory Affairs
Date of Preparation
August 11, 2026
Revision
1.0

Disclaimer

The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Peptide.Express and its Affiliates shall not be held liable for any damage resulting from handling or from contact with the above product. For Research Use Only — Not for Human Consumption.